GE HealthCare Technologies Inc. with ticker code (GEHC) now have 12 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range between the high target price and low target price is between $97.00 and $82.00 suggesting an average analyst share price target price of $89.79. (at the time of writing). Now with the previous closing price of $83.17 this is indicating there is a potential upside of 8.0%. The day 50 moving average is $74.85 while the 200 day moving average is $73.71. The company has a market cap of 37.37B. The stock price for the company is currently is currently $82.07 USD
The potential market cap would be $40,345,740,302 based on the market consensus.
The company has a dividend yield of 0.77%. Other points of data to note are a P/E ratio of 27, revenue per share of $42.97 and a 6.15% return on assets.
GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics, and digital solutions company. The Company develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. The Company’s segments include Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The Imaging segment includes scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment includes medical devices, services, consumable products, services, and digital solutions. The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the global radiology and nuclear medicine industry.
